1. Scrip
  2. >>Therapy Areas

Moderna Increases Minimum Supply Of Coronavirus Vaccine Doses For 2021

Company Still Anticipates Up To 1 Billion Doses

 
• By Alaric DeArment

The company’s announcement that it would supply at least 600 million doses of mRNA-1273 came as US vaccination rates have fallen far short of expectations.

COVID-19 vaccine
Moderna has increased the lower bound of vaccine doses it will produce from 500 million to 600 million. • Source: Shutterstock

Amid concerns about the rollout of vaccines against SARS-CoV-2 in the US, one of the companies that has received an emergency use authorization, Moderna, Inc., has raised the lower bound of the amount it intends to produce globally for this year.

The company said on 4 January that it would increase its base-case global production estimate for the mRNA-1273 vaccine for 2021 from 500 million to 600 million doses, while still investing and adding staff so that it can produce up to 1 billion doses in total

More from Anti-infective

More from Therapy Areas

In Brief: Positive New Data For Aptose’s Triplet Therapy In 1L AML

 
• By Sushmita Panda

Aptose’s tuspetinib triplet shows early mutation-agnostic promise in new data from Phase I/II program for frontline acute myeloid leukemia.

Chinese Firms Build Obesity Clinical Pipeline But Face Wider Hurdles

 
• By Xu Hu

Despite the ability to initiate clinical trials quickly and having strong manufacturing capacity, Chinese companies are facing multiple challenges in the obesity space.

Aldeyra Plans To File Reproxalap Again With New Dry Eye Symptom Data

 
• By Joseph Haas

The biotech hopes a third time will be the charm after two FDA complete responses, with plans to position its eye drop as offering quicker onset of action.